/
ENDV
$0.00-$0.00 (-99.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.02
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $83.3K | $310.2K | $165.8K | $73.1K | $135.4K | $140.2K | $10.0K | $0 |
| Cost of revenue | $12.9K | $93.4K | $65.4K | $15.0K | $10.0K | $654.8K | $625.2K | $0 |
| Gross profit | $70.3K | $216.8K | $100.4K | $58.1K | $125.4K | −$514.5K | −$615.2K | $0 |
| Gross margin | 84.5% | 69.9% | 60.6% | 79.5% | 92.6% | -366.9% | -6125.6% | — |
| R&D | $274.3K | $153.1K | $3.3K | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$4.2M | −$3.8M | −$2.9M | −$2.2M | −$3.3M | −$2.9M | −$1.6M | −$945.8K |
| EBITDA | −$588.5K | −$10.6M | $2.3M | −$1.5M | −$16.5M | $8.9M | −$941.4K | −$945.8K |
| Net income | −$6.4M | −$17.3M | −$395.6K | −$3.1M | −$18.5M | $6.9M | −$2.8M | −$2.2M |
| Net margin | -7729.5% | -5582.4% | -238.6% | -4247.2% | -13649.2% | 4937.6% | -27853.2% | — |
| EPS (diluted) | -17.76 | -33.56 | -0.03 | -0.05 | -0.13 | 0.01 | -0.01 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
NDONOVO THERAPEUTICS INC
NDONOVO THERAPEUTICS INC
Held by traders on TradeandTell
No one on the platform currently holds ENDV.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ENDV as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2019-12-20 | 1-for-1000reverse |
| 2014-05-15 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded ENDV yet.
